Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5

PURPOSE: Estimating risk of late distant recurrence (DR) is an important goal for managing women with hormone receptor–positive breast cancer after 5 years of endocrine treatment without recurrence. We developed and validated a simple clinicopathologic tool (Clinical Treatment Score post–5 years [CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowsett, Mitch, Sestak, Ivana, Regan, Meredith M., Dodson, Andrew, Viale, Giuseppe, Thürlimann, Beat, Colleoni, Marco, Cuzick, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049399/
https://www.ncbi.nlm.nih.gov/pubmed/29676944
http://dx.doi.org/10.1200/JCO.2017.76.4258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049399/
https://www.ncbi.nlm.nih.gov/pubmed/29676944
http://dx.doi.org/10.1200/JCO.2017.76.4258

Ejemplares similares